School of Medicine


Showing 1-50 of 305 Results

  • Deborah Kado

    Deborah Kado

    Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health

    BioDr. Kado is a board-certified, fellowship-trained doctor specializing in geriatrics. She serves as co-director of the Stanford Longevity Center. She is a professor of medicine and chief of research for the Geriatrics Section in the Department of Medicine, Division of Primary Care and Population Health. She is also the Director of the Geriatric Research, Education, and Clinical Center (GRECC) at VA Palo Alto Health Care System.

    For each patient, Dr. Kado prepares a personalized care plan. Her objective is to help all individuals maintain the best possible health and quality of life as they age.

    A special interest of Dr. Kado is bone health. She has conducted extensive research focused on osteoporosis and the related disorder hyperkyphosis.
    Since joining the UCLA faculty in 2000, she has received continuous funding for her research from the National Institutes of Health (NIH).

    She has over 100 peer-reviewed publications of her research findings in the Journal of Bone and Mineral Research, Osteoporosis International, Journal of Gerontology and Medical Sciences, Journal of Geriatric Oncology, Nature Communications, and other peer-reviewed journals.

    In 2007, she defined hyperkyphosis as a new geriatric syndrome. Her discoveries in this field were first featured in the American College or Physician’s premier internal medicine journal Annals of Internal Medicine. Later, they also appeared in a dedicated chapter in UpToDate, the electronic resource providing evidence-based clinical decision support for doctors worldwide.

    Prior to coming to Stanford, Dr. Kado practiced at UC San Diego where she started a dedicated osteoporosis clinic for patient care and research. She later broadened her research interests beyond musculoskeletal aging to study other aging-related topics such as the gut microbiome in older men and the effects of cancer treatments on aging in newly diagnosed breast cancer patients.

    Dr. Kado is a California native. She trained at UCSF and UCLA. She also earned a Master of Science degree in epidemiology at the UCLA School of Public Health, sponsored by the John Hartford Foundation.

    She is a member of the American Geriatrics Society, American Society of Bone and Mineral Research, Gerontological Society of America, The Endocrine Society, and other professional organizations. She co-chairs the NIH National Institute on Aging Workshop for the American Society of Bone and Mineral Research. She also participates in the Bone Health Working Group of the Society for Women’s Health Research.

  • David Kahn, M.D.

    David Kahn, M.D.

    Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery

    Current Research and Scholarly InterestsCosmetic surgery and the study of changes associated with the aging appearance of the face.

    1. Analysis and development of new procedures for aesthetic surgery of the face
    2. Analysis of the changes the face undergoes with age in the bone and soft tissues
    3. Analysis of techniques for rhinoplasty
    4. Evaluation of optimal techniques for aesthetic and reconstructive breast surgery

  • James Kahn

    James Kahn

    Professor of Medicine (General Medical Disciplines), Emeritus

    Current Research and Scholarly InterestsMy initial research activities involved antiretroviral and novel therapeutic treatments of HIV infection, understanding elements of HIV pathogenesis associated with acute HIV infection and post exposure prevention. My most recent scholarly activities concentrate on working as a team to capitalize on the data stored in electronic medical records, HIV disease modeling and using electronic medical records for outcome research and developing a mentorship program for early career scientists.

  • Alexander D. Kaiser

    Alexander D. Kaiser

    Instructor, Cardiothoracic Surgery

    BioAlexander D. Kaiser is a computational scientist and applied mathematician who researches modeling and simulation of heart mechanics. He is an Instructor at Stanford University in Cardiothoracic Surgery working with Michael Ma and in the Cardiovascular Biomechanics Computation Laboratory with Alison Marsden. His doctoral work focused on the mitral valve.

  • Pooja Kakar

    Pooja Kakar

    Member, Maternal & Child Health Research Institute (MCHRI)

    Current Research and Scholarly InterestsAs a breastfeeding medicine physician, I am passionate about advocating for mother-infant dyads and supporting their breastfeeding journeys. Additionally, I am interested studying and addressing disparities in initiation and duration of breastfeeding, particularly in lower-resourced populations, by building and advancing community partnerships.

    I am also interested in the use of digital health tools to advance upstream determinants of health in community-based settings. My current funded research projects include: 1) Providing a telehealth-based, weight control program to children with obesity from lower-income, racial and ethnic minority families (Gardner GOALS) and 2) Assessing and addressing disparities in healthy behaviors in families from under-resourced settings through the use of a secure, multilingual mobile neighborhood app (Our Voice: Beyond Clinic Walls).

  • Anusha Kalbasi, M.D.

    Anusha Kalbasi, M.D.

    Associate Professor of Radiation Oncology (Radiation Therapy)

    BioDr. Kalbasi is a board-certified radiation oncologist and physician-scientist at the Stanford Cancer Institute. He is also an associate professor of radiation oncology at Stanford Medicine and a project member of the Parker Institute for Cancer Immunotherapy.

    In the clinic, Dr. Kalbasi specializes in the diagnosis and treatment of solid tumors, especially sarcoma and melanoma, with a focus on bringing new treatments to patients. This focus includes using advanced techniques in radiation oncology and cancer immunotherapy.

    Dr. Kalbasi's NIH-funded laboratory studies the cancer-immune interface in various therapeutic contexts, including T cell therapy, cytokine therapy and innate immune agonism. The lab has described tumor cell-, T cell- and myeloid cell-intrinsic mechanisms of resistance to therapy and approaches to overcome therapy resistance. Dr. Kalbasi is also an experienced leader of clinical trials related to immunotherapy, T cell therapy and radiation therapy.

    Prior to his arrival at Stanford Health Care, Dr. Kalbasi was assistant professor of radiation oncology in the David Geffen School of Medicine at UCLA and chief of sarcoma radiotherapy at the UCLA Jonsson Comprehensive Cancer Center. During his tenure, he was named a NextGen Star by the American Association of Cancer Research in recognition for excellence in cancer research.

    Dr. Kalbasi’s work has been published in leading journals including Nature, Science Translational Medicine, JAMA Oncology, Lancet Oncology, Nature Cancer and Cancer Discovery. He has served as a peer reviewer for multiple prestigious journals, including the Proceedings of the National Academy of Sciences, Cell and the Journal of Clinical Investigation. He has also presented research to his peers at the American Association for Cancer Research and the American Institute of Chemical Engineers.

  • Agnieszka Kalinowski

    Agnieszka Kalinowski

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioI am a translational physician-scientist focused on studying the role of the immune system in patients with schizophrenia. My work spans careful clinical characterization of patients to understanding mechanisms in basic science model systems, allowing to provide mechanistic understanding to observations in clinical samples. Currently, I'm focused on deciphering the role of the complement system and how the known genetic risk translates into pathophysiological disease mechanisms. I hope that this work will pave the way to novel treatment strategies.

  • Nathan Kalinowski, D.M.D.

    Nathan Kalinowski, D.M.D.

    Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. Nathan Kalinowski is a Hospital Dentist and Clinical Assistant Professor in Dental Medicine and Surgery. He performs medically necessary dental clearance and extractions for patients preparing for cardiac surgery, radiation therapy, or organ transplantation. He also performs surgical treatment of infection and trauma to the teeth and supporting alveolar bone including reconstruction using dental implants.

  • Praveen Kalra

    Praveen Kalra

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    BioDr. Praveen Kalra is Board Certified in Anesthesia and in Critical Care. He specializes in trauma, orthopedic, brain and spine surgery, urology, and cancer surgery. He was appointed Fellow of the American Society of Anesthesiology (FASA) in 2023. Appointed Medical Director of Sustainability for Stanford Healthcare in Dec 2023.

    His professional interests include devising protocols for patient safety, informed consent, reducing the impact of anesthetics on the environment, addressing climate change by reducing green house gas emissions in the health care setting, resident education to emphasize evidence based safe care and mentoring medical students. He has been in practice for over 18 years.

    Received the Inaugural Sustainability Ambassador Award in 2022 at SHC for removing Desflurane (anesthetic gas with highest global warming potential) from the OR and undertaking multiple initiatives such as creating a Green Team at SHC, an elective Green Rotation for residents, green curriculum video series and addressing plastic & biohazardous waste in the OR. Current projects are focused on decommissioning nitrous oxide pipelines in the OR. As Medical Director of Sustainability, I work on collaborating with experts, fostering clinician engagement in change management, and spearheading transformative initiatives.

    Dr. Kalra completed his residency in Anesthesia from Harvard Medical School’s Beth Israel Deaconess Hospital and a fellowship in Critical Care from Johns Hopkins Hospital, Baltimore.

  • Julia Kaltschmidt

    Julia Kaltschmidt

    Associate Professor of Neurosurgery

    Current Research and Scholarly InterestsThe lab’s primary research interest is to understand how specific neuronal circuits are established. We use mouse genetics, combinatorial immunochemical labeling and high-resolution laser scanning microscopy to identify, manipulate, and quantitatively analyze synaptic contacts within the complex neuronal milieu of the spinal cord and the enteric nervous system.

  • Neil M. Kalwani

    Neil M. Kalwani

    Clinical Instructor, Medicine - Cardiovascular Medicine

    BioNeil Kalwani, MD, MPP is a Clinical Instructor in the Division of Cardiovascular Medicine and Director of Preventive Cardiology at the VA Palo Alto Health Care System. He attended college at Yale University and completed graduate degrees in medicine and public policy at Harvard University. He trained in internal medicine at Brigham and Women’s Hospital before arriving at Stanford in 2018 for fellowship in cardiovascular medicine, during which he served as Chief Fellow. He then completed a postdoctoral fellowship through the Stanford-AHRQ Health Services Research Training Program in the Department of Health Policy. His clinical focus is in general and preventive cardiology and echocardiography. He practices at the VA Palo Alto Health Care System and at Stanford Health Care.

    Dr. Kalwani's research focuses on the evaluation of policies and care delivery innovations designed to improve the value of care for patients with cardiovascular disease.

  • Afrin N. Kamal, MD MS

    Afrin N. Kamal, MD MS

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    BioAfrin Kamal is a board-certified gastroenterologist, who trained at Washington University in internal medicine, Cleveland Clinic in gastroenterology/hepatology, and most recently Stanford University in esophageal and motility diseases. Afrin shares a clinical passion in esophageal motility diseases with an an overlapping interest in health services and outcomes research.

  • Robin Kamal MD MBA

    Robin Kamal MD MBA

    Associate Professor of Orthopaedic Surgery

    Current Research and Scholarly InterestsWrist and Elbow Injuries and Quality Measures in Orthopaedic Surgery

  • Tahereh Kamali

    Tahereh Kamali

    Instructor, Neurology & Neurological Sciences

    Current Research and Scholarly InterestsAI for Healthcare, Neuroimaging, Biomarkers Development

  • Aya Kamaya, MD

    Aya Kamaya, MD

    Professor of Radiology (Body Imaging)

    Current Research and Scholarly InterestsHepatobiliary imaging
    Hepatocellular carcinoma
    Urologic imaging
    Gynecologic imaging
    Thyroid imaging
    Novel ultrasound technologies
    Perfusion CT imaging of abdominal tumors

  • Neeraja Kambham

    Neeraja Kambham

    Professor of Pathology

    Current Research and Scholarly InterestsDr. Kambham's research interests primarily involve medical diseases and transplantation pathology of the kidney and liver.

  • Komal Kamra

    Komal Kamra

    Clinical Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsPediatric Cardiac Anesthesia
    Transesophageal Echocardiography
    Adult Congenital Heart Disease
    Clinical Informatics

  • Matthew Kanan

    Matthew Kanan

    Professor of Chemistry

    BioAssociate Professor of Chemistry Matthew Kanan develops new catalysts and chemical reactions for applications in renewable energy conversion and CO2 utilization. His group at Stanford University has recently developed a novel method to create plastic from carbon dioxide and inedible plant material rather than petroleum products, and pioneered the study of “defect-rich” heterogeneous electro-catalysts for converting carbon dioxide and carbon monoxide to liquid fuel.

    Matthew Kanan completed undergraduate study in chemistry at Rice University (B.A. 2000 Summa Cum Laude, Phi Beta Kappa). During doctoral research in organic chemistry at Harvard University (Ph.D. 2005), he developed a novel method for using DNA to discover new chemical reactions. He then moved into inorganic chemistry for his postdoctoral studies as a National Institutes of Health Postdoctoral Research Fellow at the Massachusetts Institute of Technology, where he discovered a water oxidation catalyst that operates in neutral water. He joined the Stanford Chemistry Department faculty in 2009 to continue research into energy-related catalysis and reactions. His research and teaching have already been recognized in selection as one of Chemistry & Engineering News’ first annual Talented 12, the Camille Dreyfus Teacher-Scholar Award, Eli Lilly New Faculty Award, and recognition as a Camille and Henry Dreyfus Environmental Mentor, among other honors.

    The Kanan Lab addresses fundamental challenges in catalysis and synthesis with an emphasis on enabling new technologies for scalable CO2 utilization. The interdisciplinary effort spans organic synthesis, materials chemistry and electrochemistry.

    One of the greatest challenges of the 21st century is to transition to an energy economy with ultra-low greenhouse gas emissions without compromising quality of life for a growing population. The Kanan Lab aims to help enable this transition by developing catalysts and chemical reactions that recycle CO2 into fuels and commodity chemicals using renewable energy sources. To be implemented on a substantial scale, these methods must ultimately be competitive with fossil fuels and petrochemicals. With this requirement in mind, the group focuses on the fundamental chemical challenge of making carbon–carbon (C–C) bonds because multi-carbon compounds have higher energy density, greater value, and more diverse applications that one-carbon compounds. Both electrochemical and chemical methods are being pursued. For electrochemical conversion, the group studies how defects known as grain boundaries can be exploited to improve CO2/CO electro-reduction catalysis. Recent work has unveiled quantitative correlations between grain boundaries and catalytic activity, establishing a new design principle for electrocatalysis, and developed grain boundary-rich copper catalysts with unparalleled activity for converting carbon monoxide to liquid fuel. For chemical CO2 conversion, the group is developing C–H carboxylation and CO2 hydrogenation reactions that are promoted by simple carbonate salts. These reactions provide a way to make C–C bonds between un-activated substrates and CO2 without resorting to energy-intensive and hazardous reagents. Among numerous applications, carbonate-promoted carboxylation enables the synthesis of a monomer used to make polyester plastic from CO2 and a feedstock derived from agricultural waste.

    In addition to CO2 chemistry, the Kanan group is pursuing new strategies to control selectivity in molecular catalysis for fine chemical synthesis. Of particular interest in the use of electrostatic interactions to discriminate between competing reaction pathways based on their charge distributions. This effort uses ion pairing or interfaces to control the local electrostatic environment in which a reaction takes place. The group has recently shown that local electric fields can control regioselectivity in isomerization reactions catalyzed by gold complexes.

  • Beverley Kane

    Beverley Kane

    Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioBeverley Kane, MD, was Board Certified in Family Medicine, then completed fellowships in Ob-Gyn (San Francisco Children's Hosptial) and Sports Medicine (London Univeristy). She has worked in the private practice of sports medicine; in medical informatics, specializing in doctor-patient communication (WebMD); and in stress management with her private practice, Horsensei Equine-Assisted Learning & THerapy (HEALTH). Her latest book, "Equine-imity--Stress Reduction and Emotional Self-Regulation in the Company of Horses," published 27 March 2021, can be seen at http://equine-imity.com/

  • Guson Kang

    Guson Kang

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Kang is an interventional cardiologist who specializes in the treatment of structural heart disease. He has expertise in complex coronary interventions, transcatheter aortic and mitral valve replacements, transcatheter mitral valve repair, left atrial appendage occlusion, PFO/septal defect closure, alcohol septal ablation, and paravalvular leak closure.

    A Bay Area native, he graduated from Stanford University and obtained his medical degree at Yale University. He came back to Stanford to train in internal medicine, cardiology, and interventional cardiology before completing an advanced structural interventions fellowship at Ford Hospital.

  • Ming Jeffrey Kao, PhD, MD

    Ming Jeffrey Kao, PhD, MD

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly Interests1. Patient-reported outcomes. Efficient, multi-feature item-response theory (IRT) based computerized adaptive testing (CAT) algorithm using item banks from PROMIS and NIH Toolbox

    2. Activity monitoring. Novel analytic framework for physical activity monitoring in the context of pain.

    3. Operations research. Multi-variable discrete and continuous optimization for Lean Hospital Management

    4. National trends in pain medication prescription

  • Peter Kao

    Peter Kao

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly InterestsOur research program has several active projects:
    1.) Pulmonary Vascular Disease – Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
    2.) Lung inflammation and regeneration (stem cells)
    3.) Lung surfactant rheology and oxidative stress
    4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms

  • Michael S. Kapiloff, MD, PhD

    Michael S. Kapiloff, MD, PhD

    Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.

    URL to NCBI listing of all published works:
    http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending

    For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html

  • Katherine Kaplan

    Katherine Kaplan

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsDr. Kaplan's research interests span four (often overlapping) domains: (1) pathophysiologic aspects of insomnia and hypersomnia in mood disorders, including mechanisms, correlates, and sequelae of these sleep disturbances; (2) behavioral interventions for sleep disturbances in adults and adolescents; (3) circadian and psychosocial factors impacting sleep in adolescence; and (4) machine learning approaches to big data.

  • Michael J. Kaplan, MD

    Michael J. Kaplan, MD

    Professor of Otolaryngology - Head & Neck Surgery at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests1) New therapeutic approaches for head and neck cancer, including immune stimulation possibilities (IRX-2 protocol), integration of biological modifiers, and, eventually, genetic approaches.
    2) Head and neck cancer stem cells: identification, characterization, control--in conjunction with the Irv Weissman and Michael Clarke labs in the Stem Cell Institute
    3) Development of innovative surgical methods at the anterior cranial base

  • Robert Kaplan

    Robert Kaplan

    Adjunct Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsHealth services research
    Studies on the cost and quality of health care
    Health outcome measurement
    Social determinants of health

  • Daniel Kapp

    Daniel Kapp

    Professor of Radiation Oncology, Emeritus

    Current Research and Scholarly InterestsGynecologic malignancies; Rectal/and cancer; Breast Cancer; Hodgkin's disease; Hyperthermia; intraoperative radiation therapy; High dose rate radiation therapy; Predictive assays; Patterns of tumor spread; Health care finance.